Mental Health Diagnostics/ Meditation Apps

Cybin to Present at Psychedelics in Psychiatry Virtual Conference

Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will be presenting at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17, 2021. The presentation details are as follows:

Date: Thursday, June 17, 2021

Time: On demand, beginning at 7:00 AM ET


The presentation will be webcast on-demand and available for 90 days thereafter using the link provided above.

Mr. Drysdale will also be participating in a panel discussion at 9:00AM ET: Disruptive Psychopharmacology – An Introduction to Psychedelics and the Coming Revolution in Psychiatry.

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to

Related posts

Onduo Expands Virtual Care Solution Platform into Mental Health

Business Wire

Virtual Therapeutic Platform Reulay Announces Results From Study

Business Wire

Worldwide Sensor Patch Industry Expected to Reach $1.6 Bn by 2026

PR Newswire